(1)
Oertle, S.; Mauron, H.; Villiger, P. Inhibition of the TNF-Pathway: Use of Infliximab and Etanercept As Remission-Inducing Agents in Cases of Therapy-Resistant Chronic Inflammatory Disorders. Swiss Med Wkly 2002, 132, 414-414.